サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433533

細胞療法の市場規模、シェア、動向分析レポート：治療タイプ別、治療領域別、地域別、セグメント予測、2024年～2030年

Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
細胞療法の市場規模、シェア、動向分析レポート：治療タイプ別、治療領域別、地域別、セグメント予測、2024年～2030年
出版日: 2024年01月02日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞療法市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、細胞療法の世界市場の規模は2030年までに200億7,000万米ドルに達し、2024年から2030年までのCAGRは22.66％で拡大すると予測されています。

市場関係者の間では、組織、遺伝子、細胞に基づく先進的な治療法の開拓に対する関心が高まっています。研究コミュニティや企業は、新規治療法の開発のために、ケラチノサイト、軟骨細胞、軟骨細胞、幹細胞、皮膚乳頭細胞、上皮細胞など幅広い種類の細胞の培養や分離に大規模な投資を続けています。

FDAのような規制当局は、先進的な治療法の開発・承認や規制外の治療法の制限に関するイニシアチブをとることで、市場の成長に重要な役割を果たしています。また、直接的な細胞初期化は、有効性や安全性などの利点があるため、最先端の治療法として関心を集めています。

一方、先端治療に関連する臨床試験の増加が、今後数年間の市場成長を押し上げると予想されます。米国遺伝子・細胞治療学会（American Society of Gene &Cell Therapy）から入手したデータによると、2022年第1四半期には32件の非遺伝子組換え細胞治療薬の臨床試験が開始され、そのうち69％が非腫瘍領域でした。さらに、ClinicalTrials.govによると、1800以上の細胞治療が臨床試験中です。

さらに、同市場で事業を展開する主要企業は、市場での存在感を高めるため、さまざまな契約、新規上市、事業拡大など、いくつかの戦略的取り組みを行っています。例えば、2022年5月、ペンシルバニア大学の個別化細胞療法が再発または抵抗性の濾胞性リンパ腫の治療薬として承認されました。

さらに2021年4月、ブリストル・マイヤーズスクイブ社は、R/R大細胞型B細胞リンパ腫の成人患者を対象とした新規CAR T治療薬であるブレイヤンジ（リソカブタジェン・マラレウセル）を米国FDAが承認したと発表しました。3L+LBCLを対象とした重要な臨床試験であるTRANSCEND NHL 001において、Breyanziは73%の全奏効率と54%の完全奏効（CR）を示しました。

細胞療法市場レポートハイライト

  • 自己細胞療法分野は、生命を脅かす合併症のリスクが低いことと、この治療法の採用が増加していることから、2023年には91.22%の最大売上シェアで市場を独占しました。
  • 同種療法分野は、高価格設定や幹細胞バンクの成長などの要因により、今後数年間で大きく成長すると予想されます。さらに、多くの企業が同種細胞治療製品開発への事業シフトを準備しています。
  • がん治療領域は2023年に最大の市場シェアを獲得したが、これは様々な種類のがんの治療において先進的な細胞療法の採用が増加しているためです。
  • 細胞療法は筋骨格系疾患でも検討されており、市場成長の大きな可能性を秘めています。
  • 北米は、強力な規制の枠組み、国際細胞治療学会のような機関の存在、主要事業会社の存在により、市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 細胞療法市場の分類：治療タイプの推定・動向分析

  • 同種他家由来の細胞療法
    • 同種他家由来細胞療法の世界市場、2018年から2030年
    • 幹細胞療法
    • 非幹細胞療法
  • 自己由来の細胞療法
    • 自己由来の細胞療法の世界市場、2018年から2030年
    • 幹細胞療法
    • 非幹細胞療法

第5章 細胞療法市場の分類：治療領域の推定・動向分析

  • 細胞療法市場：治療領域の変動分析
  • 腫瘍学
    • 腫瘍治療のための細胞療法の世界市場、2018年から2030年
  • 心血管疾患（CVD）
    • 心血管疾患に対する細胞療法の世界市場
  • 筋骨格系疾患
    • 筋骨格系疾患治療のための細胞療法の世界市場、2018年から2030年
  • 皮膚科
    • 皮膚科治療における細胞療法の世界市場、2018年から2030年
  • その他
    • その他の治療法の細胞療法の世界市場、2018年から2030年

第6章 細胞療法市場の分類：地域別の推定・動向分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の地域

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル・一覧表
    • Novartis AG
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb Company
    • Johnson &Johnson Services, Inc
    • JCR Pharmaceuticals Co., Ltd.
    • JW Therapeutics
    • Atara Biotherapeutics
    • MEDIPOST
    • Anterogen Co., Ltd.
    • S. BIOMEDICS
図表

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 Global Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 3 Global Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Therapy Market By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 Canada Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 Europe Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 14 Europe Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 15 Germany Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 17 UK Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 18 UK Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Switzerland Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 20 Switzerland Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 China Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 25 China Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 26 Japan Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 27 Japan Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 India Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 29 India Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 30 South Korea Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 31 South Korea Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 32 Rest Of The World Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 33 Rest Of The World Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cell Therapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 PESTEL Analysis
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Global Cell Therapy Market: Therapy Type Key Takeaways
  • Fig. 12 Global Cell Therapy Market: Therapy Type Movement Analysis
  • Fig. 13 Global Cell Therapy Market For Allogeneic Therapies, 2018 - 2030 (USD Million)
  • Fig. 14 Global Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 15 Global Cell Therapy Market For Hematopoetic Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Therapy Market For Keratinocyte & Fibroblast-Based Therapies, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Therapy Market For Autologous Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
  • Fig. 29 Global Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 30 Global Cell Therapy Market: Therapeutic Area Key Takeaways
  • Fig. 31 Global Cell Therapy Market: Therapeutic Area Movement Analysis
  • Fig. 32 Global Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
  • Fig. 36 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2023 & 2030
  • Fig. 38 North America Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 44 Switzerland Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 50 Rest Of The World Cell Therapy Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-701-8

Cell Therapy Market Growth & Trends:

The global cell therapy market size is expected to reach USD 20.07 billion by 2030, expanding at a CAGR of 22.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market players are witnessing an increasing interest in the development of advanced therapies that are based on tissue, genes, or cells. Research communities and companies continue to make large investments in the culturing and isolation of a broad range of cell types, such as keratinocytes, chondrocytes, cartilage, stem, dermal papilla, & epithelial cells for the development of novel therapies.

Regulatory authorities such as FDA play a crucial role in the growth of the market by undertaking initiatives related to the development and approval of advanced treatment development as well as restriction of unregulated treatments. In addition, direct cellular reprogramming is attracting interest as a cutting-edge treatment approach because of its advantages such as efficacy and security.

On the other hand, an increase in the number of clinical trials related to advanced therapies is expected to boost the market growth in the coming years. According to data obtained from the American Society of Gene & Cell Therapy, in Q1 2022, 32 non-genetically modified cellular therapeutics trials were initiated, and 69% of these were in the non-oncology arena. Moreover, according to ClinicalTrials.gov, more than 1800 active cellular therapies are under clinical trial.

Furthermore, key companies operating in the market are undertaking several strategic initiatives such as various agreements, new launches, and expansion to strengthen their market presence. For instance, in May 2022, the University of Pennsylvania's personalized cellular therapy was approved for the treatment of individuals with relapsed or resistant follicular lymphoma.

Moreover, in April 2021, Bristol Myers Squibb declared that U.S. FDA approved its Breyanzi (lisocabtagene maraleucel), a novel CAR T treatment for adults with R/R large B-cell lymphoma. In the pivotal trial for 3L+ LBCL, TRANSCEND NHL 001, Breyanzi showed a 73% overall response rate and a 54% complete response (CR) rate.

Cell Therapy Market Report Highlights:

  • The autologous therapy segment dominated the market with the largest revenue share of 91.22% in 2023, owing to increasing adoption of this therapy type coupled with lower risk of life-threatening complications
  • The allogenic therapy segment is expected to grow significantly in the coming years owing to factors such as high pricing and growth in stem cell banking. Moreover, many companies are preparing to shift their business toward allogenic cell therapy product development
  • Oncology therapeutic area captured the largest market share in 2023, owing to the increasing adoption of advanced cell therapies in the treatment of various types of cancers
  • Cell therapy are also under the investigation for musculoskeletal disorders and has great potential for market growth
  • North America dominated the market owing to the strong regulatory framework, presence of bodies like the International Society for Cellular Therapy, and presence of key operating companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Type Segment
    • 1.1.2. Therapeutic Area Segment
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List Of Secondary Sources
  • 1.8. List Of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Landscape Insights

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rise In The Number Of Clinical Studies Pertaining To The Development Of Cellular Therapies
      • 3.2.1.2 Rising Adoption Of Regenerative Medicine
      • 3.2.1.3 Introduction Of Novel Platforms And Technologies
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Ethical Concerns Related To Stem Cell Research
      • 3.2.2.2 Clinical Issues Pertaining To Development & Implementation Of Cell Therapy
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTEL Analysis
    • 3.3.3 COVID-19 Impact Analysis

Chapter 4 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis

  • 4.1 Allogeneic Cell Therapy
    • 4.1.1 Global Allogeneic Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.1.2 Stem Cell Therapies
      • 4.1.2.1 Global Allogeneic Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.2 Hematopoeitic Stem Cell Therapies
      • 4.1.2.2.1 Global Allogeneic Cell Therapy Market For Hematopoeitic Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.3 Mesenchymal Stem Cell Therapies
      • 4.1.2.3.1 Global Allogeneic Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Billion)
    • 4.1.3 Non-Stem Cell Therapies
      • 4.1.3.1 Global Allogeneic Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.2 Keratinocytes & Fibroblast-Based Therapies
      • 4.1.3.2.1 Global Allogeneic Cell Therapy Market For Keratinocytes & Fibroblast-Based Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.3 Others
      • 4.1.3.3.1 Global Allogeneic Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
  • 4.2 Autologous Cell Therapy
    • 4.2.1 Global Autologous Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.2.2 Stem Cell Therapy
      • 4.2.2.1 Global Autologous Cell Therapy Market For Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.2.2 BM, Blood, & Umbilical Cord-Derived Stem Cells
      • 4.1.2.2.1 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.3 Adipose Derived Cells
      • 4.1.2.3.1 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.4 Others
      • 4.2.2.4.1 Global Autologous Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Billion)
    • 4.2.3 Non-Stem Cell Therapy
      • 4.2.3.1 Global Autologous Cell Therapy Market For Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.3.2 T-Cell Therapies
      • 4.2.3.2.1 Global Autologous Cell Therapies Market For T-Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.2 CAR-T Cell Therapy
      • 4.2.4.2.2.1 Global Autologous Cell Therapy Market For CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.3 T-Cell Receptor (TCR)
      • 4.2.4.2.3.1 Global Autologous Cell Therapy Market For T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
      • 4.2.3.3 Others
      • 4.2.3.3.1 Global Autologous Cell Therapies Market For Other Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)

Chapter 5 Cell Therapy Market Categorization: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Cell Therapy Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Global Cell Therapy Market For Oncology Therapies, 2018 - 2030 (USD Million)
  • 5.3 Cardiovascular Disease (CVD)
    • 5.3.1 Global Cell Therapy Market For Cardiovascular Disease (CVD) Therapies, 2018 - 2030 (USD Million)
  • 5.4 Musculoskeletal Disorders
    • 5.4.1 Global Cell Therapy Market For Musculoskeletal Disorders Therapies, 2018 - 2030 (USD Million)
  • 5.5 Dermatology
    • 5.5.1 Global Cell Therapy Market For Dermatology Therapies, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Global Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Million)

Chapter 6 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis

  • 6.1 North America
    • 6.1.1 North America Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.2 U.S.
      • 6.1.2.1 Key Country Dynamics
      • 6.1.2.2 Target Disease Prevalence
      • 6.1.2.3 Competitive Scenario
      • 6.1.2.4 Regulatory Framework
      • 6.1.2.6 U.S. Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.3 Canada
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Target Disease Prevalence
      • 6.1.3.3 Competitive Scenario
      • 6.1.3.4 Regulatory Framework
      • 6.1.3.6 Canada Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Europe Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Germany
      • 6.2.2.1 Key Country Dynamics
      • 6.2.2.2 Target Disease Prevalence
      • 6.2.2.3 Competitive Scenario
      • 6.2.2.4 Regulatory Framework
      • 6.2.2.6 Germany Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Target Disease Prevalence
      • 6.2.3.3 Competitive Scenario
      • 6.2.3.4 Regulatory Framework
      • 6.2.3.6 UK Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Switzerland
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Target Disease Prevalence
      • 6.2.4.3 Competitive Scenario
      • 6.2.4.4 Regulatory Framework
      • 6.2.4.6 Switzerland Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 Japan
      • 6.3.2.1 Target Disease Prevalence
      • 6.3.2.2 Competitive Scenario
      • 6.3.2.3 Regulatory Framework
      • 6.3.2.5 Japan Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 China
      • 6.3.3.1 Target Disease Prevalence
      • 6.3.3.2 Competitive Scenario
      • 6.3.3.3 Regulatory Framework
      • 6.3.3.5 China Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 India
      • 6.3.4.1 Target Disease Prevalence
      • 6.3.4.2 Competitive Scenario
      • 6.3.4.3 Regulatory Framework
      • 6.3.4.5 India Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 South Korea
      • 6.3.5.1 Target Disease Prevalence
      • 6.3.5.2 Competitive Scenario
      • 6.3.5.3 Regulatory Framework
      • 6.3.5.5 South Korea Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Rest Of The World
    • 6.4.1 Rest Of The World Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Categorization
  • 7.2 Strategy Mapping
  • 7.3 Company Market Position Analysis, 2023
  • 7.4 Company Profiles/Listing
    • 7.4.1 Novartis AG
      • 7.4.1.1 Company Overview
      • 7.4.1.4 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 Gilead Sciences, Inc.
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Bristol-Myers Squibb Company
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Johnson & Johnson Services, Inc
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 JCR Pharmaceuticals Co., Ltd.
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 JW Therapeutics
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 Atara Biotherapeutics
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 MEDIPOST
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 Anterogen Co., Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 S. BIOMEDICS
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives